External Publications

 

Lindgren P, Buxton M, Kahan T et al (2009) The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone. Results from ASCOT, Pharmacoeconomics, vol 27 (3), pp 221-30 doi: 10.2165/00019053-200927030-00005

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mistry H, Dowie R, Young T, Gardiner M (on behalf of the TelePaed Project Team) (2007) Costs of NHS maternity care for women with multiple pregnancy compared with high-risk and low-risk singleton pregnancy, British Journal of Obstetrics and Gynaecology, vol 144, pp 1104-12

Aziz O, Rao C, Panesar S, Jones C, Morris S, Darzi A, Athanasiou T (2007) Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery, British Medical Journal, vol 334 (7594), pp 621 DOI: 10.1136/bmj.39106.476215.BE

Sharples L, Dyer M, Cafferty F, Demiris N, Freeman C, Banner N, Large S, Tsui S, Caine N, Buxton M (2006) Cost-effectiveness of ventricular assist device use in the United Kingdom: results from evaluation of ventricular assist device programme in the UK (EVAD-UK), Journal of Heart and Lung Transplantation, vol 25, no 11, pp 1336-43

Niebauer K, Dewilde S, Fox-Rushby J, Revicki DA (2006) Impact of omalizumab on quality-of-life in patients with moderate-to-severe allergic asthma, Annals of Allergy Asthma Immunology, vol 96, pp 316-26

Musgrove P, Fox-Rushby J (2006) Cost-effectiveness analysis for priority setting, In Jamison DT, Breman JG, Measham AR et al, Disease Control Priorities in Developing Countries, The World Bank/Oxford University Press, Oxford, pp 271-85

Brenzel L, Wolfson LJ, Fox-Rushby J et al (2006) Vaccine-preventable diseases, In Jamison DT, Breman JG, Measham AR et al, Disease Control Priorities in Developing Countries, The World Bank/Oxford University Press, Oxford, pp 389-411

Onwujekwe O, Hanson K, Fox-Rushby J (2006) Some indicators of socio-economic status may not be reliable and use of indices with these data could worsen equity, Health Economics Letters, vol 15, pp 639-44

Bhatia M, Fox-Rushby J (2006) Willingness to pay for insecticide-treated mosquito nets in Surat, India.  In Roberts J (ed) The Economics of Infectious Disease, Oxford University Press, pp 181-99

Mulligan JA, Walker D, Fox-Rushby J (2006) Economic evaluations of non-communicable disease interventions in developing countries: a critical review of the evidence base, Cost Effectiveness and Resource Allocation, vol 4, no 7

Hanney S, Homes PD, Frame I, Grant J, Green P, Buxton M (2006) Identifying the impact of diabetes research, Diabetic Medicine, vol 23, pp 176-84

Kogan M, Henkel M, Hanney S (2006) Government and Research: Thirty Years of Evolution.  Second Edition.  Dordrecht: Springer

Hanney S (2006) Future of Health Research in the UK.  Lancet, vol 368, pp 728-9 (letter)

Hanney S, Gonzalez-Block MA (2006) Building health research systems to achieve better health.  Health Research Policy and Systems, vol 4, no 10  http://www.health-policy-systems.com/content/pdf/1478-4505-4-10.pdf

Jones T, Hanney S, Buxton M (2006) The journals of importance to UK clinicians: a questionnaire survey of surgeons.  BMC Medical Informatics and Decision Making, doi:10.1186/1472-6947-6-24 http://hdl.handle.net/2438/674

Lindgren P, Buxton M, Kahan T et al (2005) Cost-effectiveness of atrovastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial - lipid-lowering arm (ASCOT-LLA), European Journal of Cardiovascular Prevention and Rehabilitation, vol 12, pp 29-36

Buxton M (as part of EVAR trial participants) (2005) Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. The Lancet, vol 365(9478), pp 2179-86

Trama A, Walker D, Fox-Rushby J (2005) Introducing hepatitis B virus vaccine into the expanded programme of Immunization in Bangladesh: a proposed method to evaluate whether the existing infrastructure has the capacity, Journal of Health, Population & Nutrition, vol 23, no 1, pp 25-33

Khan MM, Khan SH, Walker D, Fox-Rushby J, Cutts F, Akramazzumam SM (2005) Cost of delivering child immunization services in urban Bangladesh: a study based on facility-level surveys, Journal of Health, Population & Nutrition, vol 22, no 4, pp 404-12

Fox-Rushby J, Cairns J (Eds) (2005) Economic Evaluation, Open University Press, McGraw Hill (253 pages)

Fox-Rushby J, Johnson K, Mwanzo I, Allen T, Parker M (2005) Language and Culture: Moving between theory and practice in cross-cultural research in Revicki D and Lenderking W (eds) Advances in Health Outcomes Research Methods, Measurement, Statistical Analysis, and Clinical Applications, Kluwer, The Netherlands

Hanney S (2005) Personal interaction with researchers or detached synthesis of the evidence: modelling the health policy paradox. Evaluation and Research in Education, 18 (1-2): 72-82. (download pdf file)

Hanney S, Mugford M, Grant J, Buxton M (2005) Assessing the benefits of health research: lessons from research into the use of antenatal corticosteroids for the prevention of neonatal respiratory distress syndrome.  Social Science & Medicine, vol 60, pp 937-47

Wooding S, Hanney S, Buxton M, Grant J (2005) Payback arising from research funding: evaluation of the Arthritis Research Campaign. Rheumatology, vol 44, pp 1145-56(download pdf file)

Hanney SR, Home PD, Frame I, Grant J, Green P, Buxton MJ (2005) Identifying the impact of diabetes research, Diabetic Medicine.  DOI:10.1111/j.1464-5491.2005.01753.x

Hanney S, Frame I, Grant J, Buxton M, Young T, Lewison G (2005) Using categorisations of citations when assessing the outcomes from health research, Scientometrics, vol 65, no 3, pp 357-79

Jones T, Hanney S, Buxton M, Rippon I (2005) Journals used for the publication of English psychiatry, surgery and paediatrics research, Aslib Proceedings, 57, no 3, pp 278-90

Bryan S, Longworth L (2005) Measuring health-related utility: why the disparity between EQ-5D and SF-6D? European Journal of Health Economics, vol 6, no 3, pp 253-60

Longworth L, Buxton M, Sculpher M, Smith D (2005) Estimating utility data from clinical indicators for patients with stable angina. European Journal of Health Economics, vol 6, no 4, pp 288-97

Miners AH, Garau M, Fidan D, Fischer AJ (2005) Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study, BMJ, vol 330, pp 65-8 

Mistry H, Buxton M, Longworth L, Chatwin J, Peveler R (2005) Comparison of GP records and patient self-report questionnaires for estimation of costs, European Journal of Health Economics, vol 6, no 3, pp 261-6

Stoykova B, Fox-Rushby J (2005) Use of Economic Evaluation in Practice and Policy in Fox-Rushby J, Cairns J (eds) Economic Evaluation in Health Care: an introductory guide to practice, McGraw Hill, pp 218-31

Ratcliffe J, Young T, Longworth L, Buxton M (2005) An assessment of the impact of informative drop out and nonresponse in measuring health related quality of life using the EuroQol ( EQ-5D) descriptive system, Value in Health, vol 8, no 1, pp 53-8

Young T (2005) Estimating mean total costs in the presence of censoring: a comparative assessment of methods, PharmacoEconomics, vol 23 (12), pp 1229-42

Sculpher MJ, Smith DH, Clayton T, Henderson RA, Buxton M, Pocock SJ, Chamberlain DA (2002)

Coronary angioplasty versus medical therapy for angina.  Health service costs based on the second

Randomised Intervention Treatment of Angina (RITA-2) trial, European Heart Journal, vol 23 (16), pp

1291-1300

 

Buxton M, Ashton H, Campbell H, Day NE, Kim LG, Marteau TM, Scott RAP and Thompson SG

(on behalf of the Multicentre Aneurysm Screening Study Group) (2002) Multicentre aneurysm

screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms

based on four year results from randomised controlled trial, BMJ, vol 325, pp 1135-8

 

Scott RAP, Ashton HA, Buxton M, Day NE, Kim LG, Marteau TM, Thompson SG, Walker NM (on

behalf of the Multicentre Aneurysm Screening Study Group) (2002) The Multicentre Aneurysm

Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in

men: a randomised controlled trial, Lancet, vol 360, pp 1531-9

 

Ratcliffe J, Van Haselen, Buxton M, Hardy K, Colehan J, Partridge M (2002) Assessing patients'

preferences for characteristics associated with homeopathic and conventional treatment of asthma:

a conjoint analysis study, Thorax, vol 57 (6), pp 503-8

 

Wong WL, Campbell H, Saunders M (2002) Positron emission tomography (PET) - evaluation of

'indeterminate pulmonary lesions', Clinical Oncology, vol 14 (2), pp 123-8

 

Hanney S, Gonzalez-Block M, Buxton M, Kogan M (2002) The utilisation of health research in policy-making: concepts, examples, and methods of assessment.  A Report to the Research Policy and Co-operation Department, World Health Organisation, Geneva (Available at: http://www.who.int/rpc/documents/HealthResearchinPolicyMaking.pdf)

 

Karnon J and Brown J (on behalf of the Adjuvant Breast Cancer (ABC) Steering Committee) (2002) Tamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer.  A stochastic economic evaluation, Pharmacoeconomics, vol 20 (2), pp 119-37

 

Karnon J (2002) Planning the efficient allocation of research funds: an adapted application of a non-parametric Bayesian value of information analysis, Health Policy, vol 61, pp 329-47

 

Kennedy ADM, Leigh-Brown AP, Torgerson DJ et al (2002) Resource use data by patient report or hospital records: Do they agree? BMC Health Services Research, vol 2 (2) 

Kennedy ADM, Sculpher MJ, Coulter A et al (2002) Effects of decision aids for menorrhagia on treatment choices, health outcomes, and costs.  A randomized controlled trial, JAMA, vol 288, pp 2701-8

Publications are alphabetically ordered by name of first HERG author (in bold), and are not repeated for each HERG author.

Briggs AH, Sculpher MJ, Logan R et al (1996) Cost-effectiveness of screening for and eradication of Helicobacter pylori in the management of dyspeptic patients under 45 years of age, British Medical Journal, vol 312, pp 1321-1325

Briggs A and Sculpher M (1997) Commentary: Markov models of medical prognosis, British Medical Journal, vol 314, pp 354-355

Sharples LD, Briggs A, Caine N, McKenna M, Buxton M (1996) A model to cost main clinical events following cardiac transplantation, Transplantation, vol 62, pp 615-621

Briggs A, Sculpher M, Britton A et al (1998) The costs and benefits of primary total hip replacement. How likely are new prostheses to be cost-effective? International Journal of Technology Assessment in Health Care, vol 14, no 4, pp 743-761

Rees GJG, Richards MA, Brewin TB, Brown J, Crellin A, Fentiman IS, Hopper A & McIllmurry M (1996) Cancer care of the elderly, Journal of Cancer Care, vol 5, pp 13-17

Brown J (1996) Economic aspects of cancer screening, in Moss S and Chamberlain J (eds) Evaluation of Cancer Screening, London, Springer

Brown J, Bryan S, Warren R (1996) Mammography screening: an incremental cost effectiveness analysis of double versus single reading of mammograms, British Medical Journal, vol 312, pp 809-812

Chamberlain J, Melia J, Moss S, Brown J (1997) The diagnosis, management, treatment and costs of prostate cancer in England and Wales, Health Technology Assessment, vol 1, no 3

Chamberlain J, Melia J, S Moss, Brown J (1997) Report prepared for the health technology assessment panel of the NHS executive on the diagnosis, management, treatment and costs of prostate cancer in England and Wales, British Journal of Urology, vol 79, suppl 3, pp 1-32

Gerard K, Brown J, Johnston K (1997) The UK breast screening programme: How does it reflect the Forrest recommendations? Journal of Medical Screening, vol 4, pp 10-15

Brown J, Johnston K, Gerard K, Morton A (1998) Attending breast screening and assessment: women's costs and opinions, Radiology, vol 4, pp 121-124

Brown J, Buxton MJ (1998) The economic perspective. In Peckham C, Dezateux C (eds) Screening, British Medical Bulletin, vol 54, no 4, pp 993-1009

Brown J, Sculpher M (1999) Benefit valuation in economic evaluation of cancer therapies. A systematic review of the published literature, PharmacoEconomics, vol 16 (1), pp 17-31

Brown J (1999) Economic evaluation of cancer treatments: A review of the methods, Clinical Oncology, vol 11, pp 78-83

Brown J, Karnon J, Eldabi T, Paul R (with and on behalf of the ABC Trial Steering Committee) (1999) Using modelling in a phased approach to the economic evaluation of adjuvant therapy for early breast cancer, Critical Reviews in Oncology and Hematology, vol 32, pp 95-103

Gerard K, Johnston K, Brown J (1999) The role of a pre-scored multi-attribute health classification measure in validating condition-specific health state descriptions, Health Economics, vol 8, pp 685-99

Neuberger J, Bryan S (1997) Clinical economics review: cost-effectiveness in the therapy of liver disease, Alimentary Pharmacology & Therapeutics, vol 11, pp 61-68

Bryan S (1997) Economic evaluation of diagnostic technologies: a role for conjoint analysis (editorial), Social Sciences in Health, vol 3, no 4, pp 209-211

Bryan S (1997) The cost-effectiveness of non-steroidal anti-inflammatory drugs (NSAIDs) in Osteoarthritis, Prescriber, September, Supplement pp 9-10

Bryan S, Ratcliffe J, Neuberger JM, Burroughs AK, Gunson BK, Buxton MJ (1998) Health-related quality of life following liver transplantation, Quality of Life Research, vol 7, no 2, pp 115-120

Bryan S and Brown J (1998) Extrapolation of cost-effectiveness information to local settings, Journal of Health Services Research and Policy, vol 3, no 2, pp 108-112

Bryan S, Weatherburn G, Buxton M (1998) Reporting from PACS workstations, RAD Magazine, May

Bryan S (1998) Investment decisions in hospital imaging departments: an economic approach, Accessing the Future, Summer, Issue 2

Bryan S, Weatherburn G, Watkins J, Buxton M (1998) The benefits of hospital-wide PACS networks: a survey of clinical users of radiology services, in Horii SC and Blaine GJ (eds) pp 266-273, Proceedings of SPIE Conference on PACS Design and Evaluation: Engineering and Clinical Issues, SPIE vol 3339, San Diego, California

Bryan S, Weatherburn G, Watkins J, Walker S, Wright C, Waters B, Evans J, Buxton M (1998) PACS in an Intensive Care Unit: results from a randomised controlled trial, in Horii SC and Blaine GJ (eds) pp 284-292, Proceedings of SPIE Conference on PACS Design and Evaluation: Engineering and Clinical Issues, SPIE vol 3339, San Diego, California

Bryan S, Weatherburn G, Watkins J, Keen J, Muris N, Buxton M (1998) The costs and benefits of hospital-wide PACS networks: an overview of a comprehensive evaluation exercise, in Horii SC and Blaine Gj (eds) pp 375-380, Proceedings of SPIE Conference on PACS Design and Evaluation: Engineering and Clinical Issues, SPIE vol 3339, San Diego, California

Bryan S, Weatherburn G, Watkins J, Roddie M, Keen J, Muris N, Buxton M (1998) Radiology report times: the impact of picture archiving and communication systems, American Journal of Roentgenology, vol 170, no 5, pp 1153-1161

Bryan S, Buxton M, Sheldon R, Grant A (1998) Magnetic resonance imaging for the investigation of knee injuries: an investigation of preferences, Health Economics, vol 7, pp 595-603

Bryan S, Weatherburn G, Watkins J, Walker S et al (1998) Evaluation of a Picture Archiving and Communication System (PACS) at Glan Clwyd Hospital. Final Report, HERG, Brunel University

Bryan S, Weatherburn G, Watkins J, Keen J, Muris N, Buxton M (1998) The Evaluation of a Hospital-Wide Picture Archiving and Communication System (PACS). Report to the Department of Health of the Brunel Evaluation of the Hammersmith PACS System, HERG, Brunel University

Bryan S, Weatherburn G, Watkins J, Buxton M (1999) The benefits of hospital-wide picture archiving and communication systems: a survey of clinical users of radiology services, British Journal of Radiology, vol 72, pp 469-478

Bryan S, Weatherburn G, Buxton M et al (1999) Evaluation of a Hospital Picture Archiving and Communication System, Journal of Health Services Research and Policy, vol 4, no 4, pp 204-209

Bryan S, Buxton M, Brenna E (2000) Estimating the impact of a diffuse technology on the running costs of a hospital. A case study of a picture archiving and communication system, International Journal of Technology Assessment in Health Care, vol 16, no 3, pp 787-798

Bryan S, Gold L, Sheldon R, Buxton M (2000) Preference measurement using conjoint methods: an empirical investigation of reliability, Health Economics, vol 9, pp 385-395

Neuberger J, Bryan S (2000) Cost-effectiveness in the therapy of liver disease (First Edition), in Bodger K, Daly MJ, Heatley RV (eds) Clinical Economics of Gastroenterology, Blackwell, Oxford

Buxton M and Hanney S (1996) How can payback from health services research be assessed? Journal of Health Services Research & Policy, vol 1, no 1, pp 35-43

Buxton M and Hanney S (1996) Assessing payback on the investment in research, in M Peckham and R Smith (eds) The Scientific Basis of Health Services, BMJ Publishing Group, pp 72-81

Schulman KA, Glick H, Buxton M, Sculpher M, Backhouse M, Bell L, Eisenberg JM (1996) The economic evaluation of the FIRST study: design of a prospective analysis alongside a multinational phase III clinical trial, Controlled Clinical Trials, vol 17, pp 304-315

Buxton MJ (1996) The economics of asthma - an introduction, European Respiratory Review, vol 6, no 35, pp 105-107

Schulman KA, Buxton MJ, Glick H, Sculpher MJ et al (1996) Results of the economic evaluation of the FIRST Study: a multinational prospective economic evaluation, International Journal of Technology Assessment in Health Care, vol 12, no 4, pp 698-713

Wallwork J, Schofield P, Caine N, Sharples L, Buxton M (1996) Health technology assessment: TMR trials and tribulations, The Lancet (letter), vol 348, no 16, p 1386

Townsend J, Buxton MJ (1997) Cost effectiveness scenario analysis for a proposed trial of hormone replacement therapy, Health Policy, vol 39, pp 181-194

Patience D, Buxton MJ, Chick J, Howlett H, McKenna M, Ritson B (1997) The SECCAT Survey: (II) the alcohol related problems scale as a proxy for resource costs and quality of life in alcoholism treatment, Alcohol and Alcoholism, vol 32, no 1, pp 79-84

Buxton MJ (1997) The Canadian experience: step change a gradual evolution? pp 17-25 in Towse A (ed) Guidelines for the Economic Evaluation of Pharmaceuticals: Can the UK Learn from Australia and Canada? London: Office of Health Economics

Buxton MJ (1997) Overview of the Symposium, in Bloor K and Freemantle N (eds) Promoting cost-effective prescribing in the UK National Health Service, University of York

Buxton MJ, Drummond MF, van Hout BA (1997) Modelling in economic evaluation: an unavoidable fact of life, Health Economics, vol 6, pp 217-227

Buxton MJ (1997) Audit versus financial incentives, in Champey Y and Lévy E (eds) The Influence of Cost-Containment on Clinician Behaviour and Innovation, Proceedings of a symposium held in Paris, France. Adis International, pp 12-13

Buxton MJ (1997) Economics of transplantation in the 21st century: new scientific opportunities but greater economic problems, Transplantation Proceedings, vol 29, pp 2717-2718

Buxton M and Hanney S (1998) Evaluating the NHS research and development programme: will the programme give value for money? Journal of the Royal Society of Medicine, vol 91 (Suppl 35), pp 2-6

Dere W, Avouac B, Boers M, Buxton M et al (1998) Recommendations for the Health Economics Analysis to be Performed with a Drug to be Registered in Prevention or Treatment of Osteoporosis, Calcified Tissue International, vol 63, pp 93-97

Fitzpatrick R, Davey C, Buxton MJ, Jones DR (1998) Evaluating patient-based outcome measures for use in clinical trials, Health Technology Assessment, vol 2, no 14

Fitzpatrick R, Davey C, Buxton MJ, Jones DR (1998) Patient-assessed outcome measures. In Black N, Brazier J, Fitzpatrick (eds) pp 13-22, Health Services Research Methods. A guide to best practice, London, BMJ

Harper G, Townsend J, Buxton M (1998) The preliminary economic evaluation of health technologies for the prioritization of health technology assessments. A discussion, International Journal of Technology Assessment in Health Care, vol 14, no 4, pp 652-662

Schofield PM, Sharples LD, Caine N, Burns S, Tait S, Wistow T, Buxton M, Wallwork J (1999) The UK randomised controlled trial of transmyocardial laser revascularisation in patients with refractory angina, Lancet, vol 353, pp 519-524

Buxton M, Schneider W (1999) Assessing the 'Payback' from AHFMR-funded research, Alberta Heritage Foundation for Medical Research, Alberta, Canada

Buxton M (2000) Assessing the cost-effectiveness of homeopathic medicines: are the problems different from other health technologies? British Homeopathic Journal, vol 89, suppl 1, pp S20-S22

Buxton M (2000) Economic aspects of surgical research and development in the NHS: an overview, in Johnston K and Sussex J (eds) pp 24-32, Surgical Research and Development in the NHS - Promotion, Management and Evaluation, Office of Health Economics: London

Buxton M, Hanney S, Packwood T, Roberts S, Youll P (2000) Assessing benefits from Department of Health and National Health Service Research and Development. Public Money and Management, vol 20, no 4, pp29-34

Dowie R, Gregory R, Annis S et al (1997) Ambulance records - a mine of information, Clinician in Management, vol 6, no 3, pp 2-4

Dowie R, Gravelle H (1997) Changes in medical training and sub-specialisation: implications for service delivery, in Ferguson B, Sheldon T and Posnett J (eds) pp 51-65, Concentration and Choice in Healthcare, The Royal Society of Medicine Press Ltd: London

Dowie R, Gregory RPF, Rowsell KV et al (1998) A decision analytic approach to commissioning ambulance cardiac services, Journal of Management in Medicine, vol 12, no 2, pp 81-91

Dowie R (1998) A review of research in the United Kingdom to evaluate the implementation of clinical guidelines in general practice, Family Practice, vol 15, no 5, pp 462-470

Dowie R and Langman M (1999) Staffing of hospitals: future needs, future provision, British Medical Journal, vol 319, pp 1193-1195

Dowie R, Jones R and Robinson M (eds) (2000) Family Practice. Research on Guidelines Implementation in Primary Care, vol 17, suppl 1, Oxford University Press

Dowie R, Robinson M, Jones R (2000) Introduction, pp S1-S2 in Dowie R, Jones R and Robinson M (eds) Family Practice. Research on Guidelines Implementation in Primary Care, vol 17, suppl 1, Oxford University Press

Jones R, Dowie R, Robinson M (2000) Guidelines implementation and research in the future, pp S36-S37 in Dowie R, Jones R and Robinson M (eds) Family Practice. Research on Guidelines Implementation in Primary Care, vol 17, suppl 1, Oxford University Press

Hanney S, Davies A and Buxton M (1999) Assessing benefits from health research projects: can we use questionnaires instead of case studies? Research Evaluation, vol 8, no 3, pp 189-199

Hanney S, Packwood T, Buxton M (2000) Evaluating the Benefits from Health Research and Development Centres. A Categorization, a Model and Examples of Application, Evaluation, vol 6, no 2, pp 137-160

Johnston K, Brown J, Gerard K, O'Hanlon M, Morton A (1998) Valuing temporary and chronic health states associated with breast screening, Social Science and Medicine, vol 47, no 2, pp 213-222

Johnston K, Gerard K, Brown J (1998) Generalizing costs from trials. Analyzing center selection bias in a breast screening trial, International Journal of Technology Assessment in Health Care, vol 14, no 3, pp 494-504

Johnston K, Buxton M, Jones DR, Fitzpatrick R (1998) Collecting resource use data in clinical studies. In Black N, Brazier J, Fitzpatrick R, Reeve B (eds) pp 35-45, Health Services Research Methods: A guide to best practice, London, BMJ

Johnston K, Brown J (1999) Two view mammography screening at incident screens: cost effectiveness analysis of policy options, British Medical Journal, vol 316, pp 1097-1102

Johnston K, Buxton M, Jones DR, Fitzpatrick R (1999) Assessing the costs of healthcare technologies in clinical trials, Health Technology Assessment, vol 3, no 6

Karnon J and Brown J (1998) Selecting a decision model for economic evaluation: a case study and review, Health Care Management Science, vol 1, no 2, pp 133-140

Zuener D, Ades AE, Karnon J, Brown J, Dezateux C, Anionwu EN (1999) Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis. Health Technology Assessment, vol 3, no 11

Karnon J, Zeuner D, Brown J, Ades AE, Wonke B, Modell B (1999) Lifetime treatment costs of B thalassaemia major, Clinical and Laboratory Haematology, vol 21, pp 377-85

Karnon J, Zeuner D, Ades A, Brown J, Yardumain A (2000) The effects of neonatal screening for sickle cell disorders on lifetime treatment costs and early deaths avoided: a modelling approach, Journal of Public Health Medicine, vol 22, no 4

Karnon J and Brown J (on behalf of the Adjuvant Breast Cancer (ABC) Steering Committee) (2002) Tamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer. A stochastic economic evaluation, Pharmacoeconomics, vol 20, no 2, pp 119-137

Keen J, Packwood T (1996) Case study evaluation, in N Mays and C Pope (eds) Qualitative Research in Health Care, BMJ Publishing Group, pp 59-67

Ferguson B, Keen J (1996) Transaction costs, externalities and information technology in health care, Health Economics, vol 5, pp 25-36

Wright DM, Kennedy A, Baxter JN et al (1996) Early outcome following open versus extraperitoneal endoscopic tension-free hernioplasty a randomised clinical trial, Surgery, vol 199(5), pp 552-557

Leigh Brown AP, Lawrie HER, Kennedy ADM, Webb JAG, Torgerson DJ, Grant A (1997) Cost-effectiveness of a prize draw on response to a postal questionnaire: results of a randomised trial among orthopaedic out-patients in Edinburgh, Journal of Epidemiology and Community Health, vol 51, pp 463-464

Kennedy A and Grant A (1997) Subversion of allocation within a randomised controlled trial, Controlled Clinical Trials (abstract), vol 18 (3S), pp 77S-78S

Mardel SN, Saunders FM, Allen H, Menezes G, Edwards C, Ollernshaw L, Baddaley D, Kennedy A, Ibbotson RM (1998) Reduced quality of in-vitro clot formation with gelatin based plasma substitutes, British Journal of Anaesthesia, vol 80 (2), pp 204-207

Leigh Brown AP, Kennedy A, Grant A, Campbell J et al (1999) Development and validation of a knee specific questionnaire: The Edinburgh Knee Function Scale, The Knee, vol 6, pp 115-123

The MRC Laparoscopic Groin Hernia Trial Group (1999) Laparoscopic versus open repair of groin hernia: a randomised comparison, Lancet, vol 354, pp 185-190

McKenna M, Chick J, Buxton MJ, Howlett H, Patience D, Ritson B (1996) The SECCAT Survey: I. The costs and consequences of alcoholism, Alcohol and Alcoholism, vol 31, no 6, pp 565-576

McKenna M, Wheeldon N, Buxton MJ (1997) Costing cardiac revascularisation for economic evaluation: micro-costing versus routine data? British Journal of Medical Economics, vol 11, pp 65-79

Packwood T (1996) Clinical audit: integrating the management of quality, Health Services Management Research, vol 9, pp 155-124

Packwood T (1997) Analysing changes in the nature of health service management in England, Health Policy, vol 40, pp 91-102

Ratcliffe J, Donaldson C and Macphee S (1996) Programme budgeting and marginal analysis: a case study of maternity services, Journal of Public Health Medicine, vol 18, pp 175-182

Bodner C, Vale L, Ratcliffe J, Farrar S (1996) Using economics alongside medical audit: a case study of the management of endometriosis in women, Health Bulletin, vol 54(3), pp 204-211

Silcock J and Ratcliffe J (1996) The 1990 GP contract - meeting needs?, Health Policy, vol 36, pp 199-207

Ratcliffe J, Ryan M, Tucker J (1996) The costs of alternative types of routine antenatal care for low-risk women: shared care vs care by general practitioners and community midwives, Journal of Health Services Research and Policy, vol 1, no 3, pp 135-140

Ratcliffe J, Cairns J, Platt S (1997) Economic Evaluation of the Health Education Board for Scotland General Public Anti-Smoking Campaign, Tobacco Control, vol 6, pp 104-110

Bodner C, Garratt A, Ratcliffe J et al (1997) Measuring health related quality of life in women with endometriosis, Health Bulletin, vol 55, pp 109-117

Ryan M, Ratcliffe J, Tucker J (1997) Using willingness to pay to value alternative models of antenatal care, Social Science and Medicine, vol 44, pp 371-380

Ratcliffe J, Ades AE, Sculpher M, Briggs A, Gibb DM (1997) Prevention of mother-to-child transmission of HIV-1 infection: alternative strategies and their cost effectiveness. Proceedings of the Sixth European conference on clinical aspects and treatment of HIV infections, Hamburg /97, 605, 113

Ratcliffe J, Gibb D, Sculpher M, Briggs A, Ades AE(1998) Alternative strategies for prevention of mother to child transmission of HIV-1 infection and their cost effectiveness, Aids, vol 12, pp 1381-1388

Ratcliffe J, Young T, Eldabi T (1999) Using simulation modelling techniques to facilitate the management of the waiting list for liver transplantation (abstract), Value in Health, vol 2, p 141

Ratcliffe J and Buxton M (1999) Patients' preferences regarding the process and outcomes of life-saving technology. An application of conjoint analysis to liver transplantation, International Journal of Technology Assessment in Health Care, vol 15, no 2, pp 340-351

Ratcliffe J (1999) Public preferences for the allocation of donor liver grafts: a comparison of the QALY and social conjoint analysis models (abstract), Medical Decision Making, vol 19, p 522

Ratcliffe J, Longworth L, Boulton M (1999) Using conjoint analysis to assess women's preferences for maternity care during the intrapartum stage (abstract), Value in Health, vol 2, p 367

Ades A, Sculpher M, Gibb D, Gupta R, Ratcliffe J (1999) Cost-effectiveness analysis of antenatal HIV screening in the United Kingdom, British Medical Journal, vol 319, pp 1230-1234

Ratcliffe J (2000) The use of conjoint analysis to elicit willingness to pay values: proceed with caution? International Journal of Technology Assessment in Health Care, vol 16, pp 270-275

Ratcliffe J (2000) Public preferences for the allocation of donor liver grafts for transplantation, Health Economics, vol 9, pp 137-148

Ratcliffe J, Young T, Eldabi T, Buxton M, Burroughs A, Paul R, Patheodoridis G and Rolles K (2000) Evaluating alternative policies for liver transplantation: a simulation modelling approach. Proceedings of the 7th International Conference on Systems Science in Health Care, 194

Ades AE, Ratcliffe J, Gibb D, Sculpher M (2000) Economic issues in the prevention of HIV vertical transmission, Pharmacoeconomics, vol 18, pp 9-22

Ryan M, Ratcliffe J (2000) Some issues in the application of closed-ended willingness to pay studies to valuing health goods: an application to antenatal care in Scotland, Applied Economics, vol 32, pp 643-651

Stevens A, Robert G, Gabbay J (1997) Identifying new health care technologies in the United Kingdom, International Journal of Technology Assessment in Health Care, vol 13 (1), pp 59-67

Robert G and Stevens A (1997) Should General Practitioners refer patietns directly to physical therapists? British Journal of General Practice, vol 47, pp 311-318

Robert G and Kennedy P (1997) Establishing the cost-effectiveness of atypical neuroleptics (editorial), British Journal of Psychiatry, vol 171, pp 103-104

Robert G, Gabbay J, Stevens A (1998) Which are the best information sources for identifying emerging health care technologies? An international Delphi survey, International Journal of Technology Assessment in Health Care, vol 14, no 4, pp 636-643

Stevens A, Packer C, Robert G (1998) Early warning of new health care technologies in the United Kingdom, International Journal of Technology Assessment in Health Care, vol 14, no 4, pp 680-686

Robert G, Stevens A, Gabbay J (1998) Horizon scanning: early identification of new health care technologies, pp 215-225 in Black N, Brazier J, Fitzpatrick R, Reeves B (eds) Health Services Research Methods. A guide to best practice, BMJ Publishing: London

Robert G and Milne R (1999) A Delphi study to establish national cost-effectiveness research priorities for positron emission tomography, European Journal of Radiology, vol 30, pp 54-60

Robert G, Stevens A, Gabbay J (1999) 'Early warning systems' for identifying new healthcare technologies, Health Technology Assessment, vol 3, no 13

Robert G and Milne R (1999) Positron emission tomography: establishing priorities for health technology assessment, Health Technology Assessment, vol 3, no 16

Robert G (1999) Science and technology. Trends and issues forward to 2015: implications for health care. In Dargie C (ed) Policy Futures for UK Health. London, Nuffield Trust

Robert G, Caine N, Sharples L, Buxton M, Large SR, Wallwork J (1999) Assessing low volume, high cost, potentially life saving surgical interventions: how and when? Left ventricular assist devices (LVADs) as a case study, Journal of Evaluation in Clinical Practice, vol 5(4), pp387-91

Robert G (1999) Science and technology. Trends and issues forward to 2015: implications for health care. In Dargie C (ed) Policy Futures in the UK Health. London: The Nuffield Trust

Robert G, Brown J, Garvican L (2000) Cost of quality management and information provision for screening: colorectal cancer screening, Medical Screening, vol 7, pp 31-34

Sculpher MJ, Dwyer N, Byford S, Stirrat G (1996) Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health-related quality of life and costs two years after surgery, British Journal of Obstetrics and Gynaecology, vol 103, pp 142-149

Sculpher M, Michaels J, McKenna M, Minor J (1996) A cost-utility analysis of laser-assisted angioplasty for peripheral arterial occlusions, International Journal of Technology Assessment in Health Care, vol 12, no 1, pp 104-125

Sculpher MJ (1996) Economic evaluation in obstetrics and gynaecology, in Bailliere's Clinical Obstetrics and Gynaecology, vol 10, pp 661-676

Sculpher M, Drummond M, Buxton M (1997) The iterative use of economic evaluation as part of the process of health technology assessment, Journal of Health Services Research and Policy, vol 2, no 1, pp 26-30

Sculpher M (1998) A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia, International Journal of Technology Assessment in Health Care, vol 14, no 2, pp 302-319

Sculpher M (1998) The cost-effectiveness of preference-based treatment allocation: the case of hysterectomy versus endometrial resection in the treatment of menorrhagia, Health Economics, vol 7, pp 129-142

Wellwood J, Sculpher M, Stoker D et al (1998) Randomised controlled trial of laparoscopic versus open mesh repair for inguinal hernia: outcome and cost, British Medical Journal, vol 317, pp 103-110

Sculpher M, Gibb D, Ades AE, Ratcliffe J, Duong T (1998) Modelling the costs of paediatric HIV infection and AIDS: comparison of infected children born to screened and unscreened mothers, AIDS, vol 12, pp 1371-1380

Sculpher M, Petticrew M, Kelland J, Elliott RA, Holdright DR, Buxton M (1998) Resource allocation for chronic stable angina: a systematic review of effectiveness, costs and cost-effectiveness of alternative interventions, Health Technology Assessment, vol 2, no 10

Fitzpatrick R, Shortall E, Sculpher MJ et al (1998) Primary total hip replacement surgery: a structured review of outcomes and modelling of cost-effectiveness associated with different prostheses. Health Technology Assessment, vol 2, no 20

Henderson RA, Pocock SJ, Sharp SJ, Nanchahal K, Sculpher MJ, Buxton MJ, Hampton JR (1998) Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting, The Lancet, vol 352, pp 1419-1425

Sculpher MJ, Dwyer N, Browning J et al (1998) A survey of women's preferences regarding alternative surgical treatments for menorrhagia, Health Expectations, vol 1, pp 96-105

Ades AE, Sculpher MJ, Gibb DM, Gupta R, Ratcliffe J (1999) Cost effectiveness analysis of antenatal HIV screening in United Kingdom, British Medical Journal, vol 319, pp 1230-1234

Watkins J (1999) A hospital-wide picture archiving and communication sytem (PACS): the views of users and providers of the radiology service at Hammersmith Hospital, European Journal of Radiology, vol 32, pp 106-112

Watkins J, Bryan S, Muris N, Buxton M (1999) Examining the influence of Picture Archiving Communication Systems and others factors upon the length of stay for patients with total hip and total knee replacements, International Journal of Technology Assessment in Health Care, vol 15, no 3, pp 497-505

Watkins J, Weatherburn G, Bryan S (2000) The impact of a picture archiving and communication system (PACS) upon an intensive care unit, European Journal of Radiology, vol 34, pp 3-8

Weatherburn G and Bryan S (1997) Economic Evaluation of Picture Archiving and Communications Systems (PACS), in Paterson A and Price R (eds) Current Topics in Radiography, Saunders, London

Weatherburn G, Watkins J, Bryan S & Cocks R (1997) The effect of PACS on the visualization of the lateral cervical spine and the management of patients presenting with trauma, Medical Informatics, vol 22, no 4, pp 359-368

Weatherburn G, Bryan S, Buxton M (1998) The effect of PACS on patient radiation doses for examination of the lateral lumbar spine, in Horii SC and Blaine GJ (eds) pp 274-283, Proceedings of SPIE Conference on PACS Design and Evaluation: Engineering and Clinical Issues, SPIE vol 3339, San Diego, California

Weatherburn G and Bryan S (1999) The effect of a picture archiving and communication system (PACS) on patient radiation doses for examintion of the lateral lumbar spine, British Journal of Radiology, vol 72, pp 534-545

Weatherburn G, Bryan S, West M (1999) A comparison of image reject rates when using film, hard copy computed radiography and soft copy images on picture archiving and communication systems (PACS) workstations, British Journal of Radiology, vol 72, pp 653-660

Weatherburn GC, Davies J (1999) Comparison of film, hard copy computed radiography (CR) and soft copy picture archive and communications systems (PACS) using a contrast-detail test object, British Journal of Radiology, vol 72, pp 856-863

Weatherburn GC, Bryan S, Nicholas A, Cocks RA (2000) The effect of a Picture Archiving and Communications System (PACS) on diagnostic performance in the accident and emergency department, Journal of Accident and Emergency Medicine, vol 17, pp 180-184

Weatherburn GC, Bryan S, Cousins C (2000) A comparison of the time required by radiologists for the preparation of clinico-radiological meetings when film and PACS are used, European Radiology, vol 10, pp 1006-1009

Weatherburn G, Bryan S, Davies JG (2000) Comparison of doses for bedside examinations of the chest with conventional screen-film and computed radiography: results of a randomized controlled trial, Radiology, 217, pp 707-712

Wonderling D, Langham S, Buxton M, Normand C, McDermott C (1996) What can be concluded from the Oxcheck and British family heart studies: commentary of cost effectiveness analyses, British Medical Journal, vol 312, pp 1274-1278

Wonderling D, McDermott C, Buxton MJ, Kinmonth AL, Pyke SDM, Thompson SG, Wood DA (1996) Costs and cost-effectiveness of cardiovascular screening and intervention: the British family heart study, British Medical Journal, vol 312, pp 1269-1273

Wonderling D, Karnon J (1999) Economic evaluation of health promotion programmes, in Thorogood M, Coombes Y (eds) Evaluating Health Promotion: Practice and Methods, Oxford University Press

Brown N, Young T, Gray D, Skene AM, Hampton JR (1997) Inpatient acute myocardial infarction, 1982-92: analysis of data in the Nottingham heart attack register, British Medical Journal, vol 315, pp 159-164

Brown N, Melville M, Gray D, Young T, Hampton JR (1998) Secondary prevention in a cohort of survivors following myocardial infarction: evidence that lipids are still being ignored, British Journal of Cardiology, vol 5 (9), pp 489-492

Soo LH, Gray D, Young T, Huff N, Skene A, Hampton JR (1999) Resuscitation from out-of-hospital cardiac arrest: is survival dependent on who is available at the scene? Heart, vol 81, pp 47-52

Soo LH, Gray D, Young T, Skene AM, Hampton JR (1999) Influence of ambulance crew's length of experience on the outcome of out-of-hospital cardiac arrests, European Heart Journal, vol 20, no 7, pp 535-540

Brown N, Melville M, Gray D, Young T, Skene AM, Munro J, Hampton JR (1999) Quality of life four years after acute myocardial infarction: SF-36 scores compared with a normal population, Heart, vol 81, pp 352-358

Melville M, Brown N, Gray D, Young T, Hampton J (1999) Outcome and use of health services four years after admission for acute myocardial infarction: case record follow up study, British Medical Journal, vol 319, pp 230-231

Brown N, Melville M, Gray D, Young T, Skene AM, Hampton JR (2000) Comparison of the SF-36 health survey questionnaire with the Nottingham Health Profile in long-term survivors of a myocardial infarction, Journal of Public Health Medicine, vol 22, no 2, pp 167-175

Ashby J, Buxton MJ and Gravelle H (1990) Will a breast screening programme change the workload and referral practice of general practitioners?, Journal of Epidemiology and Community Health, vol 44, no 1, pp 36-38

Maher EJ, Barton L, Ashby J and Dickson R (1990) The role of the palliative care unit in the organization of services to patients with cancer, Palliative Medicine, vol 4, pp 293-298

Ashby J, O'Hanlon M, Buxton M (1994) The time trade-off technique: how do the valuations of breast cancer patients compare to those of other groups? Quality of Life Research, vol 3, pp 257-265

Blades CA, Culyer AJ, Wiseman J, and Walker A (1986) The International Bibliography of Health Economics, Part I and Part II, Wheatsheaf Books

Blades CA and Culyer AJ (1987) Health service efficiency: appraising the appraisers', Social Science and Medicine, vol 25, no 5, pp 461-472

Shiell A, Briggs A and Farrell GC (1994) The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C, The Medical Journal of Australia, vol 160, pp 268-272

Briggs AH, Sculpher MJ and Buxton MJ (1994) Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis, Health Economics, vol 3, pp 95-104

Briggs A and Shiell A (1994) Uncertainty in the cost-effectiveness of interferon as a therapy for chronic hepatitis B: a probablistic sensitivity analysis (abstract), Theoretical Surgery, vol 9, no 3, pp 174

Shiell A, Briggs A, Farrell G (1994) Cost effectiveness of interferon in chronic acute hepatitis C (letter), The Medical Journal of Australia, vol 161, pp 170

Briggs A (1995) Sensitivity analysis in economic evaluation, Office of Health Economcis Briefing Paper No 32, September, OHE

Briggs A and Sculpher M (1995) Sensitivity analysis in economic evaluation: a review of published studies, Health Economics, vol 4, pp 355-371

Brown J, Watson E, Alberman E (1989) Screening infants for hearing loss, Archives for Diseases in Childhood, vol 64,
pp 1488-1495

Brown J (1990) An economic evaluation of the screening for hearing loss in infants, QMW Discussion Paper No 215

Brown J (1992) Screening infants for hearing loss - an economic evaluation, Journal of Epidemiology and Community Health, vol 46, pp 350-356

Brown J and Sculpher M (1993) Economics of screening programmes to prevent cervical cancer, Contemporary Reviews in Obstetrics and Gynaecology, vol 5, pp 221-229

Brown J, Rodway A, Chamberlain J et al (1994) The effect of FNA cytology on the number of diagnostic biopsies and time to diagnosis in a breast screening programme, The Breast, vol 3, pp 103-108

Brown J, Johnston K, O'Hanlon M, Morton A, Gerard K (1994) Valuing quality of life in an economic evaluation of UK breast screening clinical trials, Quality of Life (Newsletter), no 10-11, p 2

Davies C and Brown J (1994) UK cervical cancer screening programme : setting a research agenda, Journal of Medical Screening, vol 1, pp 249-254

Bryan S (1989) Charging into Confusion, The Health Service Journal, vol 99, no 5158, pp 818-9

Bryan S and Beech R (1991) Cost information in a provider market for health care: a note, Financial Accountability and Management, vol 7, no 2, pp 99-105

Bryan S, Parkin D and Donaldson C (1991) Chiropody and the QALY: a case study in assigning categories of disability and distress to patients, Health Policy, vol 18, pp 169-185

Khawaja H, Bryan S, Weaver PC (1992) Treatment of Natal Cleft Sinus: a prospective clinical and economic evaluation, British Medical Journal, vol 304, pp 1282-1283

Bryan S, Keen J, Buxton M (1992) Evaluation of Picture Archiving and Communication Systems (PACS): Issues of Methodology, in MK Chytil, G Duru, W van Eimeren, Ch D Flage (eds) Health Systems - The Challenge of Change, Omnipress, 8, Prague

Bryan S, Keen J, Buxton M, Weatherburn G (1992) Evaluation of a hospital-wide PACS: costs and benefits of the Hammersmith PACS installation, SPIE (Medical Imaging: PACS Design and Evaluation), vol 1654, pp 573-576

Bryan S and Buxton M (1992) Economic evaluation of treatments for respiratory disease, PharmacoEconomics, vol 2(3), pp 207-218

Epidemiologic and Socio-Economic Aspects of Allergic Diseases Group including Bryan S (1993) Evidence for an increase in atopic disease and possible causes, Clinical and Experimental Allergy, vol 23, pp 484-492

Bryan S, Weatherburn G, Keen J, Buxton M (1993) Evaluation of PACS at Hammersmith Hospital: Baseline Assessment of Costs and other resource-use parameters within the Radiology Department, in HU Leuke, K Inamura, CC Jaffe, R Felix, Computer Assisted Radiology, Springer-Verlag, Berlin

Bryan S, Weatherburn G, Taylor J, Buxton M (1993) Evaluation of PACS at Hammersmith Hospital: assessment of radiology department performance in the intensive care unit, SPIE (Medical Imaging: PACS Design and Evaluation), vol 1899, pp 434-440

Bryan S, Muris N, Keen J, Weatherburn G, Buxton M (1994) How can the impact of PACS on inpatient length of stay be established? SPIE (Medical Imaging: PACS Design and Evaluation), vol 2165, pp 593-600

Bryan S, Weatherburn G, Keen J, Muris N, Buxton M (1994) Technology assessment of PACS: measurement and analysis of radiologists reporting times when reporting from film, SPIE (Medical Imaging: PACS Design and Evaluation, vol 2165, pp 820-826

Bryan S and Buxton MJ (1994) The costs and benefits of liver transplantation, in Neuberger J and Lucey MR (eds) Liver Transplantation: Practice and Management, BMJ, pp 371-383

Bryan S, Buxton MJ, Scott RAP, Ashton HA (1994) Population screening for abdominal aortic aneurysm (letter), Journal of Public Health Medicine, vol 16, no 2

Bryan S, Brown J, Warren R (1995) Mammography screening: an incremental cost-effectiveness analysis of two-view versus one view procedures in London, Journal of Epidemiology and Community Health, vol 49, no 1, pp 70-78

Bryan S, Keen J, Muris N, Weatherburn G, Buxton M (1995) Issues in the evaluation of picture archiving and communication systems, Health Policy, vol 33, pp 31-42

Bryan S, Weatherburn G, Roddie M, Keen J, Muris M, Buxton MJ (1995) Explaining variation in radiologists' reporting times, The British Journal of Radiology, vol 68, pp 854-861

Bryan S, Buxton M, McKenna M, Ashton H, Scott A (1995) The private costs associated with abdominal aortic aneurysm screening: the importance of private travel and time costs, Journal of Medical Screening, vol 2, pp 62-66

Wolfe CDA, Taub NA, Bryan S, Beech R, Warburton F, Burney PGJ (1995) Variations in the incidence, management and outcome of stroke in residents under the age of 76 in two health districts of southern England, Journal of Public Health Medicine, vol 17, no 4, pp 411-418

Buxton MJ, Acheson R, Caine N, Gibson S and O'Brien BJ (1985) Costs and Benefits of Heart Transplant Programmes at Harefield and Papworth Hospitals, DHSS Research Report No 12, HMSO

Akehurst RL and Buxton MJ (1985) Option Appraisal in the NHS: A Guide to Better Decision-Making, Nuffield/York Folios no 8, Nuffield Provincial Hospital Trust

Kogan M, Buxton MJ, Henkel M, Packwood T, Radice L, and Scrivens E (1985) Evaluation of Management Advisory Service and Performance Review Trials in the NHS, King Edward's Hospital Fund for London

Buxton MJ (1986a) The UK heart transplant programmes, in International Hospital Federation, Official Yearbook, IHF, London

Buxton MJ (1986b) Cost-effectiveness of coronary grafting, Current Opinion in Cardiology, vol 1, no 6, pp 868-869

Buxton MJ (1987a) 'Problems in economic appraisal of new health technology: the evaluation of heart transplants in the UK', in M Drummond (ed) pp 103-118 Economic Appraisal of Health Technology in the European Community, Oxford Medical Publications

Buxton MJ (1987b) Economic forces and hospital technology: a perspective from Europe, International Journal of Technology Assessment in Health Care, vol 3, no 2

Buxton MJ (1987c) The economic evaluation of high technology medicine: the case of heart transplants, in A Williams (ed), Health and Economics, Macmillan

Buxton MJ (1987d) Developments in the teaching of health economics: education, training and evangelism, in G Teeling Smith (ed), Health and Economics: Prospects for the Future, Croom Helm

Buxton MJ (1987e) The cost-effectiveness of technology development: a UK view, in T B Binns and M Firth (eds), Need, demand and Resources: Health Care Provision at a Time of Financial Constraint, International Congress and Symposium Series no 115, Royal Society of Medicine, London

Buxton MJ (1988a) Heart transplantation in the UK: the decision-making context of an economic evaluation, in B Stocking (ed), Expensive Health Technologies: Regulatory and Administrative Mechanisms in Europe, CEC Health Services Research Series no 5, Oxford University Press

Buxton MJ (1988b) Managing new technology: economics research and practical decisions, Health Services Management Research, vol 1, No 1, pp 43-50

Buxton MJ and Ashby J (1988) The time trade-off approach to health state valuation, in G Teeling Smith (ed), Measuring Health: a Practical Guide, John Wiley

Buxton MJ (1989) Resource implications of heart transplantation, in J Wallwork (ed), Cardiac and Cardiopulmonary Transplantation, WB Saunders, Philadelphia

Buxton MJ (1990a) Early detection screening and diagnosis of breast cancer: private costs of attendance, pp 5-7 in Department of Health DH Yearbook of Research and Development 1989, HMSO, London

Buxton MJ (1990b) Health care systems and economic analysis, pp 20-25 in G Teeling Smith (ed) Measuring the Benefits of Medicines: the Future Agenda, Office of Health Economics reprinted in translation as 'Systèmes de santé et analyse économique', Projections (La Santé au Future), No 4, 1991, pp 13-21

Buxton MJ (1990c) Measuring and valuing health states relating to visual impairment: background and overview, pp 9-12 in Drummond MF (ed) Measuring the Quality of Life of People with Visual Impairment, National Eye Institute, US Department of Health and Human Services, Bethesda MA

Buxton MJ (1990d) The cost of new therapies, pp 152-157 in Chamberlain D, Julian D and Sleight P (eds) The Management of Acute Myocardial Ischaemia, Chapman & Hall Medical, London

Buxton MJ and Drummond MF (1990) Quality of Life Measurement in the development of medicine, Pharmaceutical Journal, vol 224, no 6574, pp 260-262

Buxton MJ, O'Hanlon M, Rushby J (and other members of the EuroQol Group) (1990) 'Euroqol - A new facility for the measurement of health related quality of life', Health Policy, vol 16, no 3, pp199-208

Jennett B and Buxton MJ (1990) When is treatment for cancer economically justified, Journal of the Royal Society of Medicine, vol 83, pp 225-228

Buxton MJ, Sculpher MJ, Ferguson BA et al (1991) Screening for treatable diabetic retinopathy: a comparison of different methods, Diabetic Medicine, vol 8, pp 371-377

Buxton MJ, Dubois DJ, Turner RR, Sculpher MJ, Robinson PA, Searcy C (1991) Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis: comparison of fluconazole and amphotericin B-based therapies, Journal of Infection, vol 23, pp 17-31

Buxton MJ (1991a) Economic evaluation studies in respiratory medicine, Respiratory Medicine, vol 85, suppl B, pp 43-46

Buxton MJ (1991b) An Economist's Perspective on Outcomes, pp 13-20 in Clarke M (ed) Outcome and Performance in Health Care 2, Public Finance Foundation, London

Buxton MJ, Keen J and Packwood T (1991) Resource Management and Organisational Change, Health Direct, October, p 10

Buxton MJ (1992) Resource Management: need for a definition, pp 161-164 in Vallance Owen A (ed) The Health Debate Live, British Medical Journal, London

Buxton MJ, O'Hanlon M and Rushby J (and other members of EuroQol Group) (1992) EuroQol - A reply and reminder, Health Policy, vol 20, pp 329-332

Buxton MJ, O'Brien BJ (1992) Economic evaluation of Ondansetron: preliminary analysis using clinical trial data prior to price setting, British Journal of Cancer, vol 66, pp S64-S67

Buxton MJ (1992) Are we satisfied with QALYs? What are the conceptual and empirical uncertainties and what must we do to make them more generally useful?, in A Hopkins (ed) Measures of the quality of life and the uses to which they may be put, pp 41-49, Royal College of Physicians, London

McNally MA, Mollan RAB, Buxton MJ (1993) Reducing the cost of post-operative deep venous thrombosis, Journal of Management in Medicine, vol 7, no 1, pp 22-28

Dubois DJ, Buxton M, Turner RR and Leeming MRG (1993) Incorporating quality of life and economic outcomes into multinational trials: experience with tenidap in rheumatoid arthritis, in Actualités en Physiopathologie et Pharmacologie Articularies, Masson: France

Buxton M (1993) Scarce resources and informed choices, pp 36-39 in Ashton D (ed) Future Trends in Medicine, Royal Society of Medicine Services Limited, London

Buxton MJ (1993) Health Economics in the 1990s, in Jonsson B and Rosenbaum J (eds) Health Economics of Depression, John Wiley

Buxton MJ (1993) International perspectives on guidelines development: approaches, challenges, and future directions. The United Kingdom, in Schubert F (ed) Proceedings of the Canadian Collaborative Workshop on Pharmacoeconomics, pp 14-18

Buxton MJ (1993) Economic appraisal and prescribing choices, Prescribers Journal, vol 33, no 4, pp 133-138

Buxton MJ (1993) RM and IT: some cautious lessons, Viewpoint, Issue 1, pp 16-17

Cave M, Burningham D, Buxton M, Hanney S, Pollitt C, Scanlan M, Shurmer M (1994) The Valuation of Changes in Quality in the Public Services, HMSO, London

Buxton MJ, Sculpher MJ (1994) Stopping of clinical trials (letter), Lancet, vol 343, p 179

Buxton MJ (1994) Achievements of audit in the NHS, Quality in Health Care, vol 3, pp S31-S34

Reekie WD and Buxton MJ (1994) Cost-effectiveness as a guide to pricing a new pharmaceutical product, South African Medical Journal, vol 84, no 7, pp 421-423

Buxton MJ (1995) Economic evaluation of therapies for end-stage heart failure, in Lewis T and Graham TR (eds) Mechanical Circulatory Support, Edward Arnold, pp 357-362

Buxton MJ (1995) National Wilms' Tumor Study: Economic Perspective, Journal of the National Cancer Institute, vol 19, pp 27-29

Ferguson BA, Buxton MJ, Drummond MF (1990) Measuring and valuing health states relating to visual impairment: a review of literature, concepts and methods', pp 69-100 in Drummond MF (ed) Measuring the Quality of Life of People with Visual Impairment, National Eye Institute, US Department of Health and Human Services, Bethesda MA

Gibson S, Buxton MJ, Caine N and OBrien BJ (1986) Measuring patient dependency, Nursing Times, 29 January

Keen JR (1987a) Briefing Guide for General Practice Premises, Polytechnic of North London Press

Keen JR (1987b) Evaluation of Colchester General Hospital, Polytechnic of North London Press

Keen JR and McKeown S (1987) Impact of Information Technology on the Design of Future Health Buildings, Polytechnic of North London Press

Keen JR (1989) Interiors: architecture in the lives of people with dementia (Review Article), International Journal of Geriatric Psychiatry, vol 4, no 5, pp 255-272

Keen J, Buxton M, Packwood T (1991) Complexity and Contradiction in NHS Computing, Public Money and Management, vol 11, no 3, pp 23-29

Keen J, Malby R (1992) Nursing Power and Practice in the UK National Health Service, Journal of Advanced Nursing, vol 17, pp 863-870

Keen J (1992) Resource Management in A Leathard (ed), Managing Change, South Bank Polytechnic

Keen J (1992) Dementia, Office of Health Economics

Keen J, Buxton M,Packwood T (1993) Doctors and resource management: incentives and goodwill, Health Policy, vol 24, pp 71-82

Keen J (1993) Dementia: Questions of Cost and Value, International Journal of Geriatric Psychiatry, vol 8, pp 369-378

Keen J, Bryan S, Weatherburn G (1993) Evaluation of PACS at Hammersmith Hospital: instrument for the assessment of the subjective views of clinical staff, SPIE (Medical Imaging: PACS Design and Evaluation), vol 1899, pp 463-474

Keen J (ed) (1994) Information Management in Health Services, Open University Press, Buckingham

Keen J (1994) Information Policy in the National Health Service, pp 16-28 in Keen J (ed) Information Management in Health Services, Open University Press, Buckingham

Keen J (1994) The Politics of Information, pp 124-134 in Keen J (ed) Information Management in Health Services, Open University Press, Buckingham

Keen J (1994) Evaluation: Informing the Future, Not Living in the Past, pp 171-183 in Keen J (ed) Information Management in Health Services, Open University Press, Buckingham

Keen JR and Muris NMA (1994) The electronic NHS: who will benefit?, in B Richards (ed) Current Perspectives in Healthcare Computing, pp 497-502

Keen J and Muris N (1994) Outsourcing: counting the long-term costs, Health Informatics Europe, vol 2(1), pp 14-15

Keen J and Muris N (1994) Ins and outs, British Journal of Healthcare Computing and Information Management, vol 11, no 4, pp 18-20

Keen J (1994) Should the National Health Service have an Information Strategy?, Public Administration, vol 72(1), pp 33-53

Keen J, Bryan S, Muris N, Weatherburn G (1994) A Model for the Evaluation of PACS, in JM Boehme, AH Rowberg, NT Wolfman (eds) Computer Applications to Assist Radiology, pp 22-29, SCAR 94, USA

Keen J (1995) The evaluation of leading edge technologies, in B Farbey, D Targett, F Land (eds) Hard Money - Soft Outcomes, pp 135-147, Alfred Waller Limited, Henley on Thames

Keen J and Muris N (1995) Information Strategy in the NHS: Issues and Challenges, Journal of Management in Medicine, vol 9, no 2, pp 57-62

Keen J and Packwood T (1995) Case study evaluation, British Medical Journal, vol 311, pp 444-446

Keen J, Bryan S, Muris N, Weatherburn G, Buxton M (1995) Evaluation of diffuse technologies: the case of digital imaging networks, Health Policy, vol 34, pp 153-166

Kerrison S and Pfeffer N (1990) After screening. A report on diagnostic services for breast cancer in the Greater London area. Greater London Association of Community Health Councils

Kerrison S (1990) A diplomat in the job. Diabetes nursing and the changing division of labour in diabetic care. Research Paper 4, Health and Social Services Research Unit, South Bank Polytechnic

Kerrison S (1990) Responsibility without authority, Nursing Times, Sept 26th, vol 86, no 39, p 51

Kerrison S (1992) Taking stock of medical audit, Health Direct, December, p 9

Kerrison S, Packwood T, Buxton M (1993) Medical Audit: Taking Stock, Kings Fund Centre Medical Audit Series No. 6, Kings Fund Centre, London

Kerrison S (1993) Contracting and the Quality of Medical Care, in Tilley I (ed) Managing the Internal Market, Paul Chapman

Kerrison S, Packwood T, Buxton M (1994) Monitoring Medical Audit, pp 155-177 in Robinson R and Le Grand J (eds) Evaluating the NHS Reforms, Kings Fund Institute

O'Brien BJ (1986a) Measuring the benefits: the case of heart transplants in D Reis Miranda and D Langrehr (eds), The ICU - A Cost-Benefit Analysis, International Congress Series no 709, Elsevier, Amsterdam

O'Brien BJ (1986b) What Are My Chances Doctor? - A Review of Clinical Risks, Office of Health Economics

O'Brien BJ (1987a) Matching organ supply with growing demand, Health Services Journal, vol 97, no 5050, p 561

O'Brien BJ (1987b) Multiple Sclerosis, Office of Health Economics

O'Brien BJ, Buxton MJ and Ferguson B (1987) Measuring the effectiveness of heart transplant programmes: quality of life data and their relationship to survival analysis, Journal of Chronic Diseases, vol 40, suppl 1, pp 137S-153S

O'Brien BJ (1988a) Assessment of treatment in heart disease in G Teeling Smith (ed), Measuring Health: a Practical Guide, John Wiley

O'Brien BJ (1988b) The Economics of cardiac therapy, Topics in Circulation, vol 3, no 2, p 4

O'Brien BJ (1988c) A game-theoretic approach to donor kidney sharing, Social Science and Medicine, vol 26, no 11, pp 1109-1116

O'Brien BJ , Banner NR, Gibson S, Yacoub MH (1988) The Nottingham Health Profile as a measure of quality of life following combined heart and lung transplantation, Journal of Epidemiology and Community Health, vol 42, no 3, pp 232-234

O'Brien BJ, Buxton MJ, and Khawaja HT (1988) The reduction of infusion failure using transdermal glyceryl trinitrate: a decision analysis (Abstract), Theoretical Surgery, vol 385, no 1, p 46

Martin R, Ladusans E, Parsons J, O'Brien BJ, Radley-Smith R and Yacoub MH (1988) Pulmonary stenosis after anatomic correction of transposition of the great arteries, (Abstract), Circulation, Supplement II, vol 78, no 4, p 86

O'Brien BJ (1989a) Words or numbers? The evaluation of probability expressions in general practice, Journal of Royal College of General Practitioners, vol 39, no 320, pp 98-100

O'Brien BJ (1989b) The economic evaluation of patient package inserts, in M Bogaert et al (eds), Patient Package Inserts as a Source of Drug Information, International Congress Series 853, Excerpta Medica, Amsterdam

O'Brien BJ (1989c) Indicative drug budgets for general practitioners: a prescription for change, British Medical Journal, vol 298, pp 944-946

O'Brien BJ (1989d) The effect of patient charges on the utilisation of prescription medicines, Journal of Health Economics, vol 8, pp 109-132

O'Brien BJ (1989e) An overview of the estimation and evaluation of clinical risks in Mann RD (ed) Risk and Consent to Risk in Medicine, Carnforth, Parthenon Publishing

O'Brien BJ (1989f) AIDS and subjective risk assessment: a critical review, Health Policy, vol 13, pp 213-224

Ladusans EJ, Parsons JM, Baker EJ, Martin R, O'Brien BJ , Deverall PB, Tynan M, Radley-Smith RC and Yacoub MH (1989) Total correction of the tetralogy of fallot: assessment of survival (Abstract), British Heart Journal, vol 61, no 1, p 61

Khawaja HT, O'Brien BJ, Buxton MJ and Weaver PC (1989) Cost minimisation study of transdermal glyceryl trinitrate in reducing failures of peripheral intravenous infusion, British Medical Journal, vol 299, p 97

O'Brien BJ (1990) Risk assessment in psychopharmacology: the case of antidepressants in Hidmarch I and Stonier PD (eds) Psychopharmacology: Measures and Methods Volume 3, Wiley and Sons

O'Brien BJ and Rushby J (1990) Outcome assessment in cardiovascular cost-benefit studies, American Heart Journal, vol 119, pp 740-748

O'Brien BJ, Buxton MJ, and Khawaja HT (1990) An economic evaluation of transdermal glyceryl trinitrate in the prevention of intravenous infusion failure, Journal of Clinical Epidemiology, vol 43, no 8, pp 757-763

O'Brien BJ, Elswood J and Calin A (1990) Perception of prescription drug risks: a survey of patients with ankylosing spondylitis, Journal of Rheumatology, vol 17, no 4, pp 503-7

O'Brien BJ, Elswood J and Calin A (1990) Willingness to accept risk in the treatment of rheumatic disease, Journal of Epidemiology and Community Health, vol 44, no 3, pp 249-252

Martin RP, Quereshi SA, Ettedgui JA, Baker EJ, O'Brien BJ , Deverall PB, Yates AK, Maisey MN, Radley-Smith R, Tynan M, Yacoub MH (1990) An evaluation of right and left ventricular function after anatomical correction and intra-arterial repair operations for complete transposition of the great arteries, Circulation, vol 82, pp 808-816

O'Brien BJ (1991) Cholesterol and Coronary Heart Disease: Consensus or Controversy?, Office of Health Economics

O'Brien BJ, Buxton MJ and Rushby JA (1992) Cost-effectiveness of the implantable cardioverter defibrillator: a preliminary analysis, British Heart Journal, vol 68, pp 241-245

Rusthoven J, O'Brien BJ, Rocchi A (1992) Ondansetron versus metoclopramide in the prevention of chemotherapy-induced nausea and vomiting: a meta-analysis, International Journal of Oncology, vol 1, pp 443-450

O'Brien BJ, Buxton MJ, Patterson DL (1993) Relationship between Functional Status and Health-Related Quality-of-Life after Myocardial Infarction, Medical Care, vol 31, no 10, pp 950-955

Mugford M, Banfield P, OHanlon M (1991) Effects of feedback of information on clinical practice: a review, British Medical Journal, vol 303, pp 398-402

Banfield PJ, O'Hanlon M, Chapple JC, Mugford M, Beard RW (1992) How clinicians respond to computer-generated statistics in maternity care, in Richards B (ed) Current Perspectives in Healthcare Computing Conference (book), pp 367-72. British Journal of Healthcare Computing

O'Hanlon M, Rushby J, Buxton M (1994) A qualitative and quantitative comparison of the EuroQol and time trade-off techniques, International Journal of Health Sciences, vol 5, no 3, pp 85-97

Packwood T, Buxton MJ and Keen J (1989) Mapping Resource Management, Health Services Management, vol 85, no 6, pp 273-5

Henkel M, Kogan M, Packwood T, Whitaker T and Youll P (1989) The Health Advisory Service: An Evaluation, King Edwards Hospital Fund for London

Packwood T, Buxton MJ and Keen J (1990) Resource Management in the National Health Service: A first case history, Policy and Politics, vol 18, no 4, pp 245-255

Packwood T, Keen J and Buxton M (1991) Hospitals in Transition: The Resource Management Experiment, Open University Press

Packwood T (1991) The Three Faces of Medical Audit, Health Service Journal, 26 September, pp 24-26

Packwood T, Keen J, Buxton M (1992) Process and Structure: Resource Management and the Development of Sub-Unit Organisational Structure, Journal of Health Services Management Research, vol 5, no 1, pp 66-76

Packwood T, Kerrison S, Buxton M (1992) The audit process and medical organisation, Quality in Health Care, vol 1, pp 192-196

Packwood T, Kerrison S, Buxton M (1994) The implementation of medical audit, Social Policy and Administration, vol 28, no 4, pp 299-316

Packwood T (1995) Clinical audit in four therapy professions: results of an evaluation, in K Walshe (ed) Evaluating clinical audit: past lessons, future directions, pp 41-54, Royal Society of Medicine Press Limited

Ratcliffe J (1993) Extra market influences in the new NHS, Health Policy, vol 25, pp 169-183

Ratcliffe J and Healey A (1994) Priority setting in health care: the economic approach, International Journal of Management and Science, vol 10, pp 260-266

Ratcliffe J (1994) IVF: the need to evaluate value for money, Australian Health Review, vol 17, pp 75-86

Donaldson C and Ratcliffe J (1994) Economics and priority setting in the new NHS, Update, vol 48, pp 735-736

Ratcliffe J (1995) The measurement of indirect costs in economic evaluation, a critical review, Project Appraisal, vol 10, pp 13-18

Donaldson C and Ratcliffe J (1995) (eds) Economics, public health and health care purchasing, Health Policy, vol 33, no 2

Ludbrook A and Ratcliffe J (1995) The purchaser provider model: reforming health care in Scotland. Public Budgeting and Financial Management, vol 7(1), pp 122-144

Lau CP, Rushby JA, Leigh Jones M et al (1989a) A double-blind cross-over study on the symptomatology and quality of life in patients with rate responsive pacemakers (Abstract), Journal of American College of Cardiology, vol 13, no 2, p 113A

Lau CP, Rushby JA, Leigh Jones M et al (1989b) A double-blind randomised cross-over study on the symptomology and quality of life in patients with rate responsive pacemakers, Clinical Cardiology, vol 12, no 9, pp 505-512

Retinopathy Working Party (of which MJ Sculpher is a member) (1991) A protocol for screening for diabetic retinopathy in Europe, Diabetic Medicine, vol 8, pp 263-267

Sculpher MJ, Buxton MJ, Ferguson BA (1990) Economic evaluation of various alternative modalities and strategies in screening for sight-threatening diabetic retinopathy, (Abstract) Theoretical Surgery, vol 5, p 166

Sculpher MJ, Buxton MJ, Ferguson BA (1991) A cost-effectiveness analysis of screening modalities and strategies for the early detection of sight-threatening retinopathy (abstract) Medical Decision Making, vol 11, p 72

Sculpher MJ, Buxton MJ, Ferguson BA et al (1991) A relative cost-effectiveness analysis of different methods of screening for diabetic retinopathy, Diabetic Medicine, vol 8, pp 644-650

Sculpher MJ and Buxton MJ (1991a) Research needs and laser technology, in Banta D and Schou I (ed) Lasers in Health Care: Effectiveness, Cost-effectiveness and Policy Implications, Academic Publishing, Denmark

Sculpher MJ and Buxton MJ (1991b) Treatment of atherosclerotic cardiovascular disease - cost-effectiveness, in Banta D and Schou I (ed) Lasers in Health Care: Effectiveness, Cost-effectiveness and Policy Implications, Academic Publishing, Denmark

Sculpher MJ and O'Brien BJ (1991) Do patient charge increases reduce the use of prescription medicines? An economic perspective, Public Money and Management, vol 11 (summer), pp 57-62

Sculpher MJ, Buxton MJ, Ferguson BA et al (1992) Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies, Health Economics, vol 1, pp 39-51

Sculpher MJ, Bryan S, Dwyer N, Hutton J, Stirrat GM (1993) An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia, British Journal of Obstetrics and Gynaecology, vol 100, pp 244-252

Michaels JA, Minor J, Sculpher M (1993) The measurement of outcomes in vascular surgery, Auditorium, vol 1, pp 31-34

Sculpher MJ and Buxton MJ (1993) The episode-free day as a composite measure of effectiveness. An illustrative economic evaluation of formoterol versus salbutamol in asthma therapy, PharmacoEconomics, vol 4, no 5, pp 345-352

Sculpher M (1993) A preliminary economic evaluation of the diode laser in ophthalmology, Lasers in Medical Science, vol 8, pp 163-169

Sculpher MJ (1994) Health economic measures of outcome in anti-cancer treatment (abstract), British Journal of Cancer, vol 70, suppl xxii, p 4

Henderson RA, Sculpher MJ, Seed P et al (1994) Coronary angioplasty versus coronary artery bypass surgery: cost analysis based on the randomised intervention treatment of angina (RITA) trial (abstract), British Heart Journal, vol 71, p 30

Sculpher MJ, Seed P, Henderson RA, Buxton MJ et al (1994) Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial, Lancet, vol 344, pp 927,930

Sculpher M, Michaels J, McKenna M, Minor J (1994) A cost-utility analysis of laser-assisted angioplasty for peripheral vascular occlusions (abstract), Theoretical Surgery, vol 9, no 3, pp 191

Sculpher M (1994) Pharmacoeconomics: types of study and interpretation, Prescriber (suppl), pp 4-10

Sculpher M, Buxton M, Henderson R, Pocock S, Hampton J (1994) Costs of coronary angioplasty versus coronary artery bypass surgery (letter), The Lancet, pp 1574-1575

Sculpher MJ, Sargeant IR, Loizou LA, Thorpe SM, Spencer GM and Bown SG (1995) A cost analysis of Nd:YAG laser ablation versus endoscopic intubation for the palliation of malignant dysphagia, European Journal of Cancer, vol 31A, no 10, pp 1640-1646

Weatherburn G, Bryan S, Cocks R (1993) Evaluation of PACS at Hammersmith Hospital: assessment of radiology performance in the Accident and Emergency Department, SPIE (Medical Imaging: PACS Design and Evaluation), vol 1899, pp 452-458